국소 지혈제 시장 : 세계 산업 분석, 시장 규모, 점유율, 성장, 동향, 예측(2025-2032년)

Persistence Market Research has recently released a comprehensive report on the worldwide market for topical hemostats. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global topical hemostat market from 2025 to 2032.

Key Insights:

• Topical Hemostat Market Size (2025E): US$ 6.10 Bn
• Projected Market Value (2032F): US$ 11.36 Bn
• Global Market Growth Rate (CAGR 2025 to 2032): 9.3%

Topical Hemostat Market - Report Scope:

Topical hemostats play a crucial role in surgical and trauma care, aiding in the rapid control of bleeding during medical procedures. These hemostatic agents are widely used in hospitals, ambulatory surgical centers, and specialty clinics, providing effective solutions for both minor and major surgical interventions. The market encompasses a diverse range of topical hemostats, including absorbable gelatin sponges, oxidized regenerated cellulose, collagen-based hemostats, and thrombin-based products. The growing adoption of minimally invasive surgeries, an increasing number of surgical procedures worldwide, and advancements in hemostatic technologies are key factors propelling market growth.

Market Growth Drivers:

The global topical hemostat market is driven by the rising number of surgical procedures, an aging population requiring frequent medical interventions, and the increasing prevalence of chronic conditions such as cardiovascular diseases and cancer. The demand for effective bleeding control solutions is also bolstered by the growing adoption of minimally invasive and robotic-assisted surgeries. Technological advancements, such as the development of advanced hemostatic agents with enhanced biocompatibility and rapid action, further support market expansion. Additionally, increased awareness among healthcare professionals about the benefits of topical hemostats over traditional suturing methods contributes to market growth.

Market Restraints:

Despite strong growth potential, the topical hemostat market faces challenges related to stringent regulatory approvals, high product costs, and reimbursement limitations in certain regions. Stringent regulatory frameworks governing the development and commercialization of hemostatic products pose compliance challenges for manufacturers. Additionally, the relatively high cost of advanced hemostatic agents may hinder their adoption in cost-sensitive markets, particularly in emerging economies. Limited reimbursement coverage for certain topical hemostats in some healthcare systems further restricts market penetration.

Market Opportunities:

The topical hemostat market presents significant growth opportunities driven by continuous product innovation, expanding applications in various surgical specialties, and increasing adoption in ambulatory care settings. The integration of biodegradable and bioactive hemostats, along with nanotechnology-based solutions, is expected to enhance product effectiveness and expand market scope. The rising demand for point-of-care hemostatic solutions in emergency and military medical applications also creates new avenues for market expansion. Strategic collaborations, investments in R&D, and the development of cost-effective hemostatic solutions will be key to capitalizing on emerging market opportunities.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the topical hemostat market globally?
• Which product types and applications are witnessing the highest adoption across different healthcare settings?
• How are technological advancements influencing the competitive landscape of the topical hemostat market?
• Who are the key players shaping the market, and what strategies are they employing to sustain growth?
• What are the emerging trends and future prospects in the global topical hemostat market?

Competitive Intelligence and Business Strategy:

Leading players in the global topical hemostat market, including Baxter International Inc., Johnson & Johnson, B. Braun Melsungen AG, and Medtronic plc, focus on innovation, product differentiation, and strategic partnerships to strengthen their market presence. These companies invest in R&D to develop advanced hemostatic solutions, including fibrin sealants, bioabsorbable agents, and combination hemostatic technologies catering to diverse surgical needs. Collaborations with hospitals, surgical centers, and distributors facilitate market expansion and drive product adoption. Additionally, companies emphasize clinical research and physician education to enhance market acceptance and improve surgical outcomes.

Key Companies Profiled:

• Baxter International Inc.
• Johnson & Johnson
• B. Braun Melsungen AG
• Medtronic plc
• Pfizer Inc.
• Integra LifeSciences Holdings Corporation
• Stryker Corporation
• Teleflex Incorporated
• CryoLife, Inc.
• Biom'Up SAS

Topical Hemostat Market Segmentation

By Type

• Fibrin
• Thrombin
• Cellulose
• Collagen
• Gelatin
• Adhesives

By Application

• General Surgery
• Neurosurgery
• Vascular Surgery
• Cardiovascular Surgery

By End Use

• Hospitals
• Ambulatory Surgical Centers

By Region

• North America
• Europe
• East Asia
• South Asia and Oceania
• Middle East and Africa
• Latin America

Table of Contents

1. Executive Summary

• 1.1. Global Topical Hemostat Market Snapshot 2025-2032
• 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
• 1.3. Key Market Trends
• 1.4. Industry Developments and Key Market Events
• 1.5. Demand Side and Supply Side Analysis
• 1.6. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Scope and Definitions
• 2.2. Value Chain Analysis
• 2.3. Macro-Economic Factors
  • 2.3.1. Global GDP Outlook
  • 2.3.2. Global Textile Typeion by Region
  • 2.3.3. Global Cloths Demand by Region
  • 2.3.4. Global Knitting Machine Sales Overview
• 2.4. Forecast Factors - Relevance and Impact
• 2.5. COVID-19 Impact Assessment
• 2.6. PESTLE Analysis
• 2.7. Porter's Five Forces Analysis
• 2.8. Geopolitical Tensions: Market Impact
• 2.9. Regulatory and Technology Landscape

3. Market Dynamics

• 3.1. Drivers
• 3.2. Restraints
• 3.3. Opportunities
• 3.4. Trends

4. Price Trend Analysis, 2019-2032

• 4.1. Region-wise Price Analysis
• 4.2. Price by Segments
• 4.3. Price Impact Factors

5. Global Topical Hemostat Market Outlook:

• 5.1. Key Highlights
• 5.2. Global Topical Hemostat Market Outlook: Type
  • 5.2.1. Introduction/Key Findings
  • 5.2.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis by Type, 2019-2024
  • 5.2.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Type, 2025-2032
    • 5.2.3.1. Fibrin
    • 5.2.3.2. Thrombin
    • 5.2.3.3. Cellulose
    • 5.2.3.4. Collagen
    • 5.2.3.5. Gelatin
    • 5.2.3.6. Adhesives
  • 5.2.4. Market Attractiveness Analysis: Type
• 5.3. Global Topical Hemostat Market Outlook: Application
  • 5.3.1. Introduction/Key Findings
  • 5.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis by Application, 2019-2024
  • 5.3.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Application, 2025-2032
    • 5.3.3.1. General Surgery
    • 5.3.3.2. Neurosurgery
    • 5.3.3.3. Vascular Surgery
    • 5.3.3.4. Cardiovascular Surgery
  • 5.3.4. Market Attractiveness Analysis: Application
• 5.4. Global Topical Hemostat Market Outlook: End Use
  • 5.4.1. Introduction/Key Findings
  • 5.4.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis by End Use, 2019-2024
  • 5.4.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by End Use, 2025-2032
    • 5.4.3.1. Hospitals
    • 5.4.3.2. Ambulatory Surgical Centers

6. Global Topical Hemostat Market Outlook: Region

• 6.1. Key Highlights
• 6.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis by Region, 2019-2024
• 6.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Region, 2025-2032
  • 6.3.1. North America
  • 6.3.2. Europe
  • 6.3.3. East Asia
  • 6.3.4. South Asia & Oceania
  • 6.3.5. Latin America
  • 6.3.6. Middle East & Africa
• 6.4. Market Attractiveness Analysis: Region

7. North America Topical Hemostat Market Outlook:

• 7.1. Key Highlights
• 7.2. Pricing Analysis
• 7.3. North America Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Country, 2025-2032
  • 7.3.1. U.S.
  • 7.3.2. Canada
• 7.4. North America Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Type, 2025-2032
  • 7.4.1. Fibrin
  • 7.4.2. Thrombin
  • 7.4.3. Cellulose
  • 7.4.4. Collagen
  • 7.4.5. Gelatin
  • 7.4.6. Adhesives
• 7.5. North America Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Application, 2025-2032
  • 7.5.1. General Surgery
  • 7.5.2. Neurosurgery
  • 7.5.3. Vascular Surgery
  • 7.5.4. Cardiovascular Surgery
• 7.6. North America Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by End Use, 2025-2032
  • 7.6.1. Hospitals
  • 7.6.2. Ambulatory Surgical Centers

8. Europe Topical Hemostat Market Outlook:

• 8.1. Key Highlights
• 8.2. Pricing Analysis
• 8.3. Europe Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Country, 2025-2032
  • 8.3.1. Germany
  • 8.3.2. Italy
  • 8.3.3. France
  • 8.3.4. U.K.
  • 8.3.5. Spain
  • 8.3.6. Russia
  • 8.3.7. Rest of Europe
• 8.4. Europe Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Type, 2025-2032
  • 8.4.1. Fibrin
  • 8.4.2. Thrombin
  • 8.4.3. Cellulose
  • 8.4.4. Collagen
  • 8.4.5. Gelatin
  • 8.4.6. Adhesives
• 8.5. Europe Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Application, 2025-2032
  • 8.5.1. General Surgery
  • 8.5.2. Neurosurgery
  • 8.5.3. Vascular Surgery
  • 8.5.4. Cardiovascular Surgery
• 8.6. Europe Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by End Use, 2025-2032
  • 8.6.1. Hospitals
  • 8.6.2. Ambulatory Surgical Centers

9. East Asia Topical Hemostat Market Outlook:

• 9.1. Key Highlights
• 9.2. Pricing Analysis
• 9.3. East Asia Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Country, 2025-2032
  • 9.3.1. China
  • 9.3.2. Japan
  • 9.3.3. South Korea
• 9.4. East Asia Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Type, 2025-2032
  • 9.4.1. Fibrin
  • 9.4.2. Thrombin
  • 9.4.3. Cellulose
  • 9.4.4. Collagen
  • 9.4.5. Gelatin
  • 9.4.6. Adhesives
• 9.5. East Asia Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Application, 2025-2032
  • 9.5.1. General Surgery
  • 9.5.2. Neurosurgery
  • 9.5.3. Vascular Surgery
  • 9.5.4. Cardiovascular Surgery
• 9.6. East Asia Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by End Use, 2025-2032
  • 9.6.1. Hospitals
  • 9.6.2. Ambulatory Surgical Centers

10. South Asia & Oceania Topical Hemostat Market Outlook:

• 10.1. Key Highlights
• 10.2. Pricing Analysis
• 10.3. South Asia & Oceania Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Country, 2025-2032
  • 10.3.1. India
  • 10.3.2. Southeast Asia
  • 10.3.3. ANZ
  • 10.3.4. Rest of SAO
• 10.4. South Asia & Oceania Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Type, 2025-2032
  • 10.4.1. Fibrin
  • 10.4.2. Thrombin
  • 10.4.3. Cellulose
  • 10.4.4. Collagen
  • 10.4.5. Gelatin
  • 10.4.6. Adhesives
• 10.5. South Asia & Oceania Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Application, 2025-2032
  • 10.5.1. General Surgery
  • 10.5.2. Neurosurgery
  • 10.5.3. Vascular Surgery
  • 10.5.4. Cardiovascular Surgery
• 10.6. South Asia & Oceania Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by End Use, 2025-2032
  • 10.6.1. Hospitals
  • 10.6.2. Ambulatory Surgical Centers

11. Latin America Topical Hemostat Market Outlook:

• 11.1. Key Highlights
• 11.2. Pricing Analysis
• 11.3. Latin America Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Country, 2025-2032
  • 11.3.1. Brazil
  • 11.3.2. Mexico
  • 11.3.3. Rest of LATAM
• 11.4. Latin America Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Type, 2025-2032
  • 11.4.1. Fibrin
  • 11.4.2. Thrombin
  • 11.4.3. Cellulose
  • 11.4.4. Collagen
  • 11.4.5. Gelatin
  • 11.4.6. Adhesives
• 11.5. Latin America Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Application, 2025-2032
  • 11.5.1. General Surgery
  • 11.5.2. Neurosurgery
  • 11.5.3. Vascular Surgery
  • 11.5.4. Cardiovascular Surgery
• 11.6. Latin America Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by End Use, 2025-2032
  • 11.6.1. Hospitals
  • 11.6.2. Ambulatory Surgical Centers

12. Middle East & Africa Topical Hemostat Market Outlook:

• 12.1. Key Highlights
• 12.2. Pricing Analysis
• 12.3. Middle East & Africa Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Country, 2025-2032
  • 12.3.1. GCC Countries
  • 12.3.2. South Africa
  • 12.3.3. Northern Africa
  • 12.3.4. Rest of MEA
• 12.4. Middle East & Africa Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Type, 2025-2032
  • 12.4.1. Fibrin
  • 12.4.2. Thrombin
  • 12.4.3. Cellulose
  • 12.4.4. Collagen
  • 12.4.5. Gelatin
  • 12.4.6. Adhesives
• 12.5. Middle East & Africa Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Application, 2025-2032
  • 12.5.1. General Surgery
  • 12.5.2. Neurosurgery
  • 12.5.3. Vascular Surgery
  • 12.5.4. Cardiovascular Surgery
• 12.6. Middle East & Africa Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by End Use, 2025-2032
  • 12.6.1. Hospitals
  • 12.6.2. Ambulatory Surgical Centers

13. Competition Landscape

• 13.1. Market Share Analysis, 2025
• 13.2. Market Structure
  • 13.2.1. Competition Intensity Mapping
  • 13.2.2. Competition Dashboard
• 13.3. Company Profiles
  • 13.3.1. BD
    • 13.3.1.1. Company Overview
    • 13.3.1.2. Type Portfolio/Offerings
    • 13.3.1.3. Key Financials
    • 13.3.1.4. SWOT Analysis
    • 13.3.1.5. Company Strategy and Key Developments
  • 13.3.2. Baxter
  • 13.3.3. Pfizer Inc.
  • 13.3.4. Medicom
  • 13.3.5. HemoSonics
  • 13.3.6. Hemostasis, LLC
  • 13.3.7. Medline Industries
  • 13.3.8. Johnson & Johnson
  • 13.3.9. Integra LifeSciences
  • 13.3.10. Teleflex Incorporated
  • 13.3.11. HemCon Medical Technologies Inc.

14. Appendix

• 14.1. Research Methodology
• 14.2. Research Assumptions
• 14.3. Acronyms and Abbreviations